Seres Therapeutics Inc (MCRB)

Seres Therapeutics Inc Stock (MCRB) Financials Data

*All numbers in millions

Period End Date	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30
Period Length	3 Months	3 Months	3 Months	3 Months	3 Months
Revenues	19.43%0.59	0.74	0.36	0.44	0.35
	23.92%16.75	22.01	21.27	19.82	22.83
Research and Development	38.83%5.59	9.14	13.20	11.68	12.62
Operating Income/Loss	24.07%-16.15	-21.27	-20.91	-19.38	-22.48
Nonoperating Income/Loss	100.52%-0.13	25.85	0.99	4.04	30.68
Income Tax Expense/Benefit	-	-	-	-	-
	455.51%-16.29	4.58	-19.91	-15.34	8.20
Attributable To Parent	455.51%-16.29	4.58	-19.91	-15.34	8.20
Available To Common Stockholders, Basic	455.51%-16.29	4.58	-19.91	-15.34	8.20
Basic Average Shares	2.84%9.98	9.71	9.58	-	8.76
Diluted Average Shares	2.41%9.98	9.75	9.58	-	8.77
Basic Earnings Per Share	446.81%-1.63	0.47	-2.08	-	0.94
Diluted Earnings Per Share	446.81%-1.63	0.47	-2.08	-	0.94